Daré Bioscience, Inc. (DARE)

0.7734 0.00 (0.00%) USD  |  NASDAQ  |  Oct 09, 16:00
0.773 0.00 (0.00%) After-Hours: 20:00
More

Daré Bioscience Revenue Estimates for Next Quarter

Revenue Estimates for Next Quarter Chart

View Revenue Estimates for Next Quarter for DARE.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00

Historical Revenue Estimates for Next Quarter Data

View and export this data back to 2024. Start Trial.
Date Value
August 17, 2026 --
August 14, 2026 --
May 18, 2026 --
May 15, 2026 --
April 09, 2026 --
March 27, 2026 --
November 14, 2025 --
November 10, 2025 --
September 04, 2025 --
August 18, 2025 --
August 16, 2025 --
Date Value
July 15, 2025 --
June 05, 2025 --
May 14, 2025 --
April 03, 2025 --
November 15, 2024 --
August 15, 2024 --
August 14, 2024 --
August 13, 2024 --
May 16, 2024 --
May 15, 2024 --
April 30, 2024 --

Revenue Estimates for Next Quarter Range, Past 5 Years

View Revenue Estimates for Next Quarter Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Revenue Estimates for Next Quarter Benchmarks

View Revenue Estimates for Next Quarter Benchmarks
Start Trial
Elite Pharmaceuticals, Inc. --
Eton Pharmaceuticals, Inc. Upgrade
ANI Pharmaceuticals, Inc. Upgrade
Corcept Therapeutics, Inc. Upgrade
Veru, Inc. Upgrade

Revenue Estimates for Next Quarter Related Metrics

Revenue Estimates for Current Quarter Upgrade
Revenue Estimates for Current Fiscal Year Upgrade
Revenue Estimates for Next Fiscal Year Upgrade
EPS Estimates for Current Quarter Upgrade
EPS Estimates for Next Quarter Upgrade
EPS Estimates for Current Fiscal Year Upgrade
EPS Estimates for Next Fiscal Year Upgrade